Trials / Completed
CompletedNCT04996901
The Chinese STEMI PPCI Registry (CSPR)
The Chinese ST-Segment Elevation Myocardial Infarction Primary Percutaneous Coronary Intervention Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,594 (actual)
- Sponsor
- Renmin Hospital of Wuhan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
Detailed description
The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention |
Timeline
- Start date
- 2021-05-22
- Primary completion
- 2021-12-05
- Completion
- 2021-12-05
- First posted
- 2021-08-09
- Last updated
- 2021-12-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04996901. Inclusion in this directory is not an endorsement.